169 related articles for article (PubMed ID: 15761509)
1. [Molecular basis of pituitary adenomas with emphasis on somatotropinomas].
Donangelo I; Gadelha M
Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):464-79. PubMed ID: 15761509
[TBL] [Abstract][Full Text] [Related]
2. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
3. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.
Yamasaki H; Mizusawa N; Nagahiro S; Yamada S; Sano T; Itakura M; Yoshimoto K
Clin Endocrinol (Oxf); 2003 Apr; 58(4):464-70. PubMed ID: 12641630
[TBL] [Abstract][Full Text] [Related]
4. TPA enhances growth hormone (GH) secretion effect of GH-releasing hormone (GHRH) by human gsp-positive pituitary somatotrophinomas.
Lei T; Bai X; Hu W; Xue D; Jiang X
J Tongji Med Univ; 1999; 19(3):237-9, 248. PubMed ID: 12840904
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
Grande IPP; Amorim PVGH; Freire ACTB; Jallad RS; Musolino NR; Cescato VA; da Silva GO; Bronstein MD; Trarbach EB
Pituitary; 2018 Aug; 21(4):355-361. PubMed ID: 29564694
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues.
Hosoi E; Yokogoshi Y; Hosoi E; Horie H; Sano T; Yamada S; Saito S
Acta Endocrinol (Copenh); 1993 Oct; 129(4):301-6. PubMed ID: 8237246
[TBL] [Abstract][Full Text] [Related]
8. Long-term in-vitro treatment of human growth hormone (GH)-secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNA levels.
Hofland LJ; Velkeniers B; vd Lely AJ; van Koetsveld PM; Kazemzadeh M; Waaijers M; Hooghe-Peters EL; Lamberts SW
Clin Endocrinol (Oxf); 1992 Sep; 37(3):240-8. PubMed ID: 1424206
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: in vitro cell culture studies.
Adams EF; Lei T; Buchfelder M; Petersen B; Fahlbusch R
J Clin Endocrinol Metab; 1995 Jul; 80(7):2077-81. PubMed ID: 7608258
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of pituitary adenomas: a review.
Suhardja AS; Kovacs KT; Rutka JT
Acta Neurochir (Wien); 1999; 141(7):729-36. PubMed ID: 10481784
[TBL] [Abstract][Full Text] [Related]
11. Human pituitary tumours: studies on genes expression.
Cherñavsky AC; Chervin A; Vitale M; Basso A; Burdman JA
Neurol Res; 1993 Feb; 15(1):2-6. PubMed ID: 8098847
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenoma pathogenesis: an update.
Rostad S
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
[TBL] [Abstract][Full Text] [Related]
15. Detection of chromosomal imbalances in growth hormone-secreting pituitary tumors by comparative genomic hybridization.
Hui AB; Pang JC; Ko CW; Ng HK
Hum Pathol; 1999 Sep; 30(9):1019-23. PubMed ID: 10492035
[TBL] [Abstract][Full Text] [Related]
16. Cellular alterations in pituitary tumors.
Spada A; Vallar L; Faglia G
Eur J Endocrinol; 1994 Jan; 130(1):43-52. PubMed ID: 7907260
[TBL] [Abstract][Full Text] [Related]
17. [Molecular aspects of pituitary tumorigenesis].
Pinto EM; Bronstein MD
Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):599-610. PubMed ID: 18604372
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of growth hormone-secreting pituitary adenomas.
Bononi PL; McCoy JP; Martinez AJ; Janosky JE; Amico JA
Horm Res; 1994; 42(6):262-6. PubMed ID: 7698721
[TBL] [Abstract][Full Text] [Related]
19. The relationship between growth hormone (GH) messenger ribonucleic acid levels and hormone release from individual cells derived from human GH-secreting pituitary adenomas.
Hofland LJ; Velkeniers B; van Koetsveld PM; Hooghe-Peters EL; Lamberts SW
Clin Endocrinol (Oxf); 1991 Jan; 34(1):5-11. PubMed ID: 2004472
[TBL] [Abstract][Full Text] [Related]
20. Oncogenesis and mutagenesis of pituitary tumors.
Sonabend AM; Musleh W; Lesniak MS
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S3-14. PubMed ID: 17004855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
